Application no. and date | 17844433.7 (espacenet) (Federated) (European Patent Register), 20170824 | Patent/reg. no. and date | DK/EP 3504187, 20250219 | Publication date | 20190703 | Priority no. and date | US 201662379175 P, 20160824, US 201662395263 P, 20160915, US 201662411511 P, 20161021, US 201662416685 P, 20161102 | EP pub. no. and date |
EP 3504187 20190703 | Effective date | | Applicant/owner | Prilenia Neurotherapeutics Ltd., Yakum Greenwork Business Park Mindspace Offices Building D
6097200 Yakum, IL | Applicant ref. no. | V2503-019-DK | Inventor | PAPAPETROPOULOS, Spyridon, 60 Thackeray Rd
Wellesley Hills MA 02481, US, SAVOLA, Juha-MATTI, Stockackerstrasse 101
4153 Reinach, CH, BOROWSKY, Beth, 11 Crimson King Trail
Flemington NJ 08822, US, GRACHEV, Igor, D., 15 Reid Lane
Millstone Twp NJ 08535, US, HAYDEN, Michael, c/o 5 Basel Street P.O. Box 3190
Petach Tikva 49131, IL, EYAL, Eli, Hahadas 12
Petah-Tikva 4932111, IL | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/451 (2006.01) , A61P 25/14 (2006.01) | Title | ANVENDELSE AF PRIDOPIDIN TIL BEHANDLING AF FUNKTIONEL TILBAGEGANG | Int. application no. | US2017048461 | Int. publication no. | WO2018039477 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|